Search Results - "van Tuyl, Lilian H. D."

Refine Results
  1. 1

    The impact of eHealth use on general practice workload in the pre-COVID-19 era: a systematic review by Keuper, Jelle, van Tuyl, Lilian H D, de Geit, Ellemarijn, Rijpkema, Corinne, Vis, Elize, Batenburg, Ronald, Verheij, Robert

    Published in BMC health services research (19-09-2024)
    “…In recent years, eHealth has received much attention as an opportunity to increase efficiency within healthcare organizations. Adoption of eHealth might…”
    Get full text
    Journal Article
  2. 2

    Remission in early rheumatoid arthritis defined by 28 joint counts: limited consequences of residual disease activity in the forefeet on outcome by van Tuyl, Lilian H D, Britsemmer, Karin, Wells, George A, Smolen, Josef S, Zhang, Bin, Funovits, Julia, van Schaardenburg, Dirkjan, Felson, David, Boers, Maarten

    Published in Annals of the rheumatic diseases (01-01-2012)
    “…Introduction The new American College for Rheumatology (ACR)/European League Against Rheumatism (EULAR) remission criteria are based on the assessment of 28…”
    Get more information
    Journal Article
  3. 3

    Normal mortality of the COBRA early rheumatoid arthritis trial cohort after 23 years of follow-up by Poppelaars, Pomme B M, van Tuyl, Lilian H D, Boers, Maarten

    Published in Annals of the rheumatic diseases (01-05-2019)
    “…Mortality in patients with rheumatoid arthritis (RA) is higher than in the general population. We investigated mortality in the COBRA-trial cohort after 23…”
    Get more information
    Journal Article
  4. 4
  5. 5
  6. 6

    Defining remission in rheumatoid arthritis: Results of an initial american college of rheumatology/european league against rheumatism consensus conference by van Tuyl, Lilian H. D., Vlad, Steven C., Felson, David T., Wells, George, Boers, Maarten

    Published in Arthritis and rheumatism (15-05-2009)
    “…Objective Due to advances in rheumatoid arthritis (RA) therapies over the last few years, an increasing proportion of patients are able to achieve a state of…”
    Get full text
    Journal Article Conference Proceeding
  7. 7

    Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis by van Tuyl, Lilian H D, Voskuyl, Alexandre E, Boers, Maarten, Geusens, Piet, Landewé, Robert B M, Dijkmans, Ben A C, Lems, Willem F

    Published in Annals of the rheumatic diseases (01-09-2010)
    “…To determine to what extent baseline measurements of the ratio receptor activator of nuclear factor-kappaB ligand (RANKL):osteoprotegerin (OPG) and C-terminal…”
    Get more information
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Patient Perspective on Remission in Rheumatoid Arthritis by VAN TUYL, Lilian H. D, SMOLEN, Josef S, WELLS, George A, SCHOLTE-VOSHAAR, Marieke, HOOGLAND, Wijnanda, BOERS, Maarten

    Published in Journal of rheumatology (01-08-2011)
    “…Absence of disease activity, or remission, is the most important treatment goal for patients with rheumatoid arthritis (RA). Since a new preliminary definition…”
    Get full text
    Journal Article Conference Proceeding
  13. 13
  14. 14

    Relevance of the new pre-cachexia and cachexia definitions for patients with rheumatoid arthritis by van Bokhorst - de van der Schueren, Marian A.E, Konijn, Nicole P.C, Bultink, Irene E.M, Lems, Willem F, Earthman, Carrie P, van Tuyl, Lilian H.D

    Published in Clinical nutrition (Edinburgh, Scotland) (01-12-2012)
    “…Summary Background & aims The recently proposed definitions of 'pre-cachexia' and 'cachexia' might offer new possibilities for the detection of malnutrition in…”
    Get full text
    Journal Article
  15. 15

    Pain, sleep and emotional well-being explain the lack of agreement between physician- and patient-perceived remission in early rheumatoid arthritis by Turk, Samina A, Rasch, Linda A, van Schaardenburg, Dirkjan, Lems, Willem F, Sanberg, Marjolein, van Tuyl, Lilian H D, Ter Wee, Marieke M

    Published in BMC rheumatology (01-01-2018)
    “…Clinical response and remission are defined in multiple ways and measured with different instruments, resulting in substantial variation of the proportion of…”
    Get full text
    Journal Article
  16. 16

    Glucocorticoid safety for treating rheumatoid arthritis by Rasch, Linda A, Bultink, Irene E M, van Tuyl, Lilian H D, Lems, Willem F

    Published in Expert opinion on drug safety (01-06-2015)
    “…Glucocorticoids (GCs) are often used in the treatment of rheumatoid arthritis and many other inflammatory diseases. Besides strong favorable effects on disease…”
    Get more information
    Journal Article
  17. 17

    Why are Dutch rheumatologists reluctant to use the COBRA treatment strategy in early rheumatoid arthritis? by van Tuyl, Lilian H D, Plass, Anne Marie C, Lems, Willem F, Voskuyl, Alexandre E, Dijkmans, Ben A C, Boers, Maarten

    Published in Annals of the rheumatic diseases (01-07-2007)
    “…Background: The Combinatietherapie Bij Reumatoide Artritis (COBRA) trial has proved that combination therapy with prednisolone, methotrexate and sulphasalazine…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Patient-reported outcomes in core domain sets for rheumatic diseases by van Tuyl, Lilian H. D., Boers, Maarten

    Published in Nature reviews. Rheumatology (01-12-2015)
    “…Key Points Patient-reported outcomes (PROs) are abundant and still accumulating The PROs included in core outcome sets can be regarded as important Most core…”
    Get full text
    Journal Article